Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in

J M Pascussi1, S Gerbal-Chaloin, L Pichard-Garcia

  • 1INSERM U128, IFR24, 1919 Route de Mende, Montpellier, 34293, France.

Insights

Inflammation reduces drug metabolism by decreasing cytochrome P450s (CYP). Interleukin-6 (IL-6) lowers pregnane X receptor (PXR) and constitutively activated receptor (CAR) expression, impairing CYP induction.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Hepatic drug metabolism is impaired during inflammation and infection.
  • This impairment is linked to cytokine-mediated downregulation of cytochrome P450s (CYP).
  • The precise mechanism of this CYP repression remains unknown.

Purpose of the Study:

  • To investigate the mechanism by which interleukin-6 (IL-6) represses hepatic drug metabolism.
  • To determine the effect of IL-6 on the expression of key drug-metabolizing enzymes and their regulatory receptors.

Main Methods:

  • Primary cultures of human hepatocytes were treated with IL-6.
  • Expression levels of PXR, CAR, dioxin receptor, and glucocorticoid receptor mRNAs were quantified.
  • CYP induction by rifampicin and phenobarbital was measured.
  • Transcriptional activity of PXR and CAR was assessed using cell-based reporter assays.

Main Results:

  • IL-6 significantly decreased the mRNA expression of PXR and CAR.
  • IL-6 did not affect the mRNA levels of the dioxin receptor or glucocorticoid receptor.
  • IL-6 reduced the induction of CYP2B6, CYP2C8, CYP2C9, and CYP3A4 by rifampicin and phenobarbital.
  • The transcriptional activity of PXR and CAR was not directly inhibited by IL-6.

Conclusions:

  • IL-6 negatively regulates the gene expression of PXR and CAR.
  • This downregulation of PXR and CAR by IL-6 leads to the loss of inducibility of key drug-metabolizing CYP enzymes.
  • The findings elucidate a mechanism for impaired drug metabolism during inflammatory conditions.

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...